133 related articles for article (PubMed ID: 29376979)
1. [Differential approaches to the treatment of acute psychosis due to the use of synthetic cannabinoids].
Kekelidze ZI; Klimenko TV; Kozlov AA; Shakhova SM
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):21-26. PubMed ID: 29376979
[TBL] [Abstract][Full Text] [Related]
2. [Acute Psychosis after Consumption of Synthetic Cannabinoids].
Mörkl S; Blesl C; Wurm WE; Tmava A
Fortschr Neurol Psychiatr; 2016 Mar; 84(3):150-4. PubMed ID: 27029042
[TBL] [Abstract][Full Text] [Related]
3. Synthetic cannabinoid-induced psychosis: two adolescent cases.
Oluwabusi OO; Lobach L; Akhtar U; Youngman B; Ambrosini PJ
J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):393-5. PubMed ID: 23083027
[No Abstract] [Full Text] [Related]
4. Psychosis and synthetic cannabinoids.
Deng H; Verrico CD; Kosten TR; Nielsen DA
Psychiatry Res; 2018 Oct; 268():400-412. PubMed ID: 30125871
[TBL] [Abstract][Full Text] [Related]
5. First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation and antipsychotic effectiveness.
Ricci V; Ceci F; Di Carlo F; Di Muzio I; Ciavoni L; Santangelo M; Di Salvo G; Pettorruso M; Martinotti G; Maina G
Psychiatry Res; 2023 Feb; 320():115053. PubMed ID: 36682093
[TBL] [Abstract][Full Text] [Related]
6. Cannabis-Induced Psychosis and an Antipsychotic-Induced Seizure: A Case Report.
Perera T; Webler R
Prim Care Companion CNS Disord; 2017 Feb; 19(1):. PubMed ID: 28157276
[No Abstract] [Full Text] [Related]
7. Psychotic Disorders in Patients Who Use Synthetic Cannabinoids.
Skryabin VY; Vinnikova MA
J Psychiatr Pract; 2019 Nov; 25(6):485-490. PubMed ID: 31821228
[TBL] [Abstract][Full Text] [Related]
8. Treatment of refractory substance-induced psychosis in adolescent males with a genetic predisposition to mental illness.
Rahmani M; Paul S; Nguyen ML
Int J Adolesc Med Health; 2014; 26(2):297-301. PubMed ID: 24762642
[TBL] [Abstract][Full Text] [Related]
9. "Spiceophrenia": a systematic overview of "spice"-related psychopathological issues and a case report.
Papanti D; Schifano F; Botteon G; Bertossi F; Mannix J; Vidoni D; Impagnatiello M; Pascolo-Fabrici E; Bonavigo T
Hum Psychopharmacol; 2013 Jul; 28(4):379-89. PubMed ID: 23881886
[TBL] [Abstract][Full Text] [Related]
10. Use of benzylglycinamide by a HIV-seropositive polysubstance user: The changing pattern of novel psychoactive substance use among youths.
Caloro M; Calabrò G; Kotzalidis GD; Cuomo I; Corkery JM; Vento AE; Lionetto L; De Filippis S; Ranieri V; Lonati D; Locatelli CA; de Pisa E; Di Tommaso A; Girardi P; Schifano F
Addict Behav; 2016 Sep; 60():53-7. PubMed ID: 27088514
[TBL] [Abstract][Full Text] [Related]
11. Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis.
Fattore L
Biol Psychiatry; 2016 Apr; 79(7):539-48. PubMed ID: 26970364
[TBL] [Abstract][Full Text] [Related]
12. Acute intoxication caused by synthetic cannabinoids 5F-ADB and MMB-2201: A case series.
Barceló B; Pichini S; López-Corominas V; Gomila I; Yates C; Busardò FP; Pellegrini M
Forensic Sci Int; 2017 Apr; 273():e10-e14. PubMed ID: 28190538
[TBL] [Abstract][Full Text] [Related]
13. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
van Amsterdam J; Brunt T; van den Brink W
J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398
[TBL] [Abstract][Full Text] [Related]
14. Could spice drugs induce psychosis with abnormal movements similar to catatonia?
Haro G; Ripoll C; Ibáñez M; Orengo T; Liaño VM; Meneu E; Hernández F; Traver F
Psychiatry; 2014; 77(2):206-8. PubMed ID: 24865202
[No Abstract] [Full Text] [Related]
15. Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: A case report.
Durand D; Delgado LL; de la Parra-Pellot DM; Nichols-Vinueza D
Clin Schizophr Relat Psychoses; 2015 Jan; 8(4):205-8. PubMed ID: 23518784
[TBL] [Abstract][Full Text] [Related]
16. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
Every-Palmer S
Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of ECT in phencyclidine-induced psychosis.
Rosen AM; Mukherjee S; Shinbach K
J Clin Psychiatry; 1984 May; 45(5):220-2. PubMed ID: 6144671
[TBL] [Abstract][Full Text] [Related]
18. Antiepileptic drugs in the treatment of neuroleptic-induced supersensitivity psychosis.
Sultan S; Chouinard G; Beaudry P
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):431-8. PubMed ID: 1972802
[TBL] [Abstract][Full Text] [Related]
19. Advanced pediatric psychopharmacology.
Vito J; Jummani R; Coffey B
J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):498-502. PubMed ID: 16958576
[No Abstract] [Full Text] [Related]
20. Synthetic Cannabinoid Receptor Agonists: a heterogeneous class of novel psychoactive substance with emerging risk of psychosis.
Whiting D
Evid Based Ment Health; 2015 Nov; 18(4):110. PubMed ID: 26363038
[No Abstract] [Full Text] [Related]
[Next] [New Search]
